Germany Germany’s research-based pharmaceutical industry is approaching a defining period as mounting pressure to curb healthcare expenditure clashes with the country’s long-established ambition to remain a leading hub for innovation, scientific research, and advanced manufacturing. Han Steutel, President of the vfa, cautions that although Germany continues to benefit from world-class scientific…
UK Drawing on a career spanning oncology drug discovery at AstraZeneca and biotech leadership as CEO of Enhanc3d Genomics, Hazel Jones is now Chief Strategy Officer at Laverock Therapeutics. We caught up with her at the Asia Summit on Global Health in Hong Kong, where the company was showcasing its programmable…
China As the global clinical development landscape becomes more fragmented and competitive, biotechs increasingly need partners that can help them navigate regulatory complexity, identify the right trial locations, and generate meaningful data quickly. In this context, Harvest Integrated Research Organization has been expanding its international footprint while positioning itself as a…
China Dr Long Jiang is the CEO of GCP ClinPlus, a Chinese CRO with operations in New Jersey. A former cardiovascular surgeon at Peking University People’s Hospital, he shifted into clinical research after a fellowship at Duke Clinical Research Institute, and later also served as a partner in a private equity firm focusing…
MEA The Middle East contains one of the world’s strongest concentrations of expertise in the rare blood disorder thalassaemia. The story starts with the high prevalence of this disease in the region – thalassaemia affects roughly one in 100,000 people globally but reaches up to ten percent of the population in…
Japan Dr Toshiaki Nagafuji leads the Innovative Drug Development Business (IDDB) at Linical after a career spanning discovery and research at Chugai and clinical development, project management, and business development at Shionogi. At Chugai, he also served as a visiting professor at Brain Research Institute, Niigata University and a visiting researcher…
Taiwan Honeybear Biosciences is emerging as a pioneering force in precision oncology, leveraging its proprietary CoNectar glycan conjugation platform to advance next-generation ADCs and ARCs. Guided by a globally experienced leadership team and supported by strategic partnerships across Asia and beyond, the Taiwan-based biotech is progressing innovative theranostic programmes towards clinical…
Korea Jinhak Kim, Executive Director and President US at C&R Research, describes the company’s evolution into a global, data-driven CRO. He outlines its strategy of matching clinical trials to regions based on cost and patient access, expanding into Southeast Asia and the US, integrating AI, and supporting biotechs with end-to-end services…
Hong Kong It is not unreasonable, at first glance, to ask why so many pharma multinationals have chosen to establish standalone affiliates in Hong Kong. After all, only 7.5 million people call Hong Kong home, putting a cap on growth potential, and it could easily be covered by affiliates based in the…
Hong Kong In 2026, regulation, policy, institutions, and expertise are aligning to ensure Hong Kong can be a player in an extremely competitive Asian clinical trials landscape. From real-world data studies to groundbreaking early-stage work in vaccines, oncology, and even cell therapy, as well as some later-stage studies for niche indications, both…
Qatar Sidra Medicine is building a vertically integrated academic medical centre where clinical care, research, and education operate as a single system to accelerate precision medicine, particularly in rare and complex paediatric diseases. In this interview, Professor Khalid Fakhro explains how the institution leverages national-scale patient cohorts, genomics infrastructure, and global…
Europe Cancer is becoming one of Europe’s defining public health and economic challenges, forcing policymakers to think far beyond treatment alone. Questions of prevention, screening, innovation, equitable access, system resilience, and global competitiveness are now increasingly intertwined. Elisabetta Zanon discusses how the European Cancer Organisation is working to keep patients at…
See our Cookie Privacy Policy Here
